Neuromuscular Blocking Agent (NMBA) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuromuscular Blocking Agent (NMBA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Neuromuscular Blocking Agent (NMBA) market is segmented into Depolarizing Non-depolarizing Segment by Application, the Neuromuscular Blocking Agent (NMBA) market is segmented into Hospital Clinic Pharmacy Others Regional and Country-level Analysis The Neuromuscular Blocking Agent (NMBA) market is analysed and market size information is provided by regions (countries). The key regions covered in the Neuromuscular Blocking Agent (NMBA) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Neuromuscular Blocking Agent (NMBA) Market Share Analysis Neuromuscular Blocking Agent (NMBA) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuromuscular Blocking Agent (NMBA) business, the date to enter into the Neuromuscular Blocking Agent (NMBA) market, Neuromuscular Blocking Agent (NMBA) product introduction, recent developments, etc. The major vendors covered: AbbVie GlaxoSmithKline Pfizer Hengrui Pharmaceutical Abbott Laboratories Fresenius Kabi Sandoz Somerset Therapeutics Guike Pharmaceutical Shanghai Pharmaceuticals Themis Medicare Nanjing King-Friend
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
1 Study Coverage 1.1 Neuromuscular Blocking Agent (NMBA) Product Introduction 1.2 Market Segments 1.3 Key Neuromuscular Blocking Agent (NMBA) Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Neuromuscular Blocking Agent (NMBA) Market Size Growth Rate by Type 1.4.2 Depolarizing 1.4.3 Non-depolarizing 1.5 Market by Application 1.5.1 Global Neuromuscular Blocking Agent (NMBA) Market Size Growth Rate by Application 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Pharmacy 1.5.5 Others 1.6 Coronavirus Disease 2019 (Covid-19): Neuromuscular Blocking Agent (NMBA) Industry Impact 1.6.1 How the Covid-19 is Affecting the Neuromuscular Blocking Agent (NMBA) Industry 1.6.1.1 Neuromuscular Blocking Agent (NMBA) Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19?s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Neuromuscular Blocking Agent (NMBA) Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Neuromuscular Blocking Agent (NMBA) Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Neuromuscular Blocking Agent (NMBA) Market Size Estimates and Forecasts 2.1.1 Global Neuromuscular Blocking Agent (NMBA) Revenue 2015-2026 2.1.2 Global Neuromuscular Blocking Agent (NMBA) Sales 2015-2026 2.2 Neuromuscular Blocking Agent (NMBA) Market Size by Region: 2020 Versus 2026 2.2.1 Global Neuromuscular Blocking Agent (NMBA) Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Neuromuscular Blocking Agent (NMBA) Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Neuromuscular Blocking Agent (NMBA) Competitor Landscape by Players 3.1 Neuromuscular Blocking Agent (NMBA) Sales by Manufacturers 3.1.1 Neuromuscular Blocking Agent (NMBA) Sales by Manufacturers (2015-2020) 3.1.2 Neuromuscular Blocking Agent (NMBA) Sales Market Share by Manufacturers (2015-2020) 3.2 Neuromuscular Blocking Agent (NMBA) Revenue by Manufacturers 3.2.1 Neuromuscular Blocking Agent (NMBA) Revenue by Manufacturers (2015-2020) 3.2.2 Neuromuscular Blocking Agent (NMBA) Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Neuromuscular Blocking Agent (NMBA) Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Neuromuscular Blocking Agent (NMBA) Revenue in 2019 3.2.5 Global Neuromuscular Blocking Agent (NMBA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Neuromuscular Blocking Agent (NMBA) Price by Manufacturers 3.4 Neuromuscular Blocking Agent (NMBA) Manufacturing Base Distribution, Product Types 3.4.1 Neuromuscular Blocking Agent (NMBA) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Neuromuscular Blocking Agent (NMBA) Product Type 3.4.3 Date of International Manufacturers Enter into Neuromuscular Blocking Agent (NMBA) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Neuromuscular Blocking Agent (NMBA) Market Size by Type (2015-2020) 4.1.1 Global Neuromuscular Blocking Agent (NMBA) Sales by Type (2015-2020) 4.1.2 Global Neuromuscular Blocking Agent (NMBA) Revenue by Type (2015-2020) 4.1.3 Neuromuscular Blocking Agent (NMBA) Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Neuromuscular Blocking Agent (NMBA) Market Size Forecast by Type (2021-2026) 4.2.1 Global Neuromuscular Blocking Agent (NMBA) Sales Forecast by Type (2021-2026) 4.2.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Type (2021-2026) 4.2.3 Neuromuscular Blocking Agent (NMBA) Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Neuromuscular Blocking Agent (NMBA) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026) 5.1 Global Neuromuscular Blocking Agent (NMBA) Market Size by Application (2015-2020) 5.1.1 Global Neuromuscular Blocking Agent (NMBA) Sales by Application (2015-2020) 5.1.2 Global Neuromuscular Blocking Agent (NMBA) Revenue by Application (2015-2020) 5.1.3 Neuromuscular Blocking Agent (NMBA) Price by Application (2015-2020) 5.2 Neuromuscular Blocking Agent (NMBA) Market Size Forecast by Application (2021-2026) 5.2.1 Global Neuromuscular Blocking Agent (NMBA) Sales Forecast by Application (2021-2026) 5.2.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Application (2021-2026) 5.2.3 Global Neuromuscular Blocking Agent (NMBA) Price Forecast by Application (2021-2026) 6 North America 6.1 North America Neuromuscular Blocking Agent (NMBA) by Country 6.1.1 North America Neuromuscular Blocking Agent (NMBA) Sales by Country 6.1.2 North America Neuromuscular Blocking Agent (NMBA) Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Neuromuscular Blocking Agent (NMBA) Market Facts & Figures by Type 6.3 North America Neuromuscular Blocking Agent (NMBA) Market Facts & Figures by Application 7 Europe 7.1 Europe Neuromuscular Blocking Agent (NMBA) by Country 7.1.1 Europe Neuromuscular Blocking Agent (NMBA) Sales by Country 7.1.2 Europe Neuromuscular Blocking Agent (NMBA) Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Neuromuscular Blocking Agent (NMBA) Market Facts & Figures by Type 7.3 Europe Neuromuscular Blocking Agent (NMBA) Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Neuromuscular Blocking Agent (NMBA) by Region 8.1.1 Asia Pacific Neuromuscular Blocking Agent (NMBA) Sales by Region 8.1.2 Asia Pacific Neuromuscular Blocking Agent (NMBA) Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Neuromuscular Blocking Agent (NMBA) Market Facts & Figures by Type 8.3 Asia Pacific Neuromuscular Blocking Agent (NMBA) Market Facts & Figures by Application 9 Latin America 9.1 Latin America Neuromuscular Blocking Agent (NMBA) by Country 9.1.1 Latin America Neuromuscular Blocking Agent (NMBA) Sales by Country 9.1.2 Latin America Neuromuscular Blocking Agent (NMBA) Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Neuromuscular Blocking Agent (NMBA) Market Facts & Figures by Type 9.3 Central & South America Neuromuscular Blocking Agent (NMBA) Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Neuromuscular Blocking Agent (NMBA) by Country 10.1.1 Middle East and Africa Neuromuscular Blocking Agent (NMBA) Sales by Country 10.1.2 Middle East and Africa Neuromuscular Blocking Agent (NMBA) Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Neuromuscular Blocking Agent (NMBA) Market Facts & Figures by Type 10.3 Middle East and Africa Neuromuscular Blocking Agent (NMBA) Market Facts & Figures by Application 11 Company Profiles 11.1 AbbVie 11.1.1 AbbVie Corporation Information 11.1.2 AbbVie Description, Business Overview and Total Revenue 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020) 11.1.4 AbbVie Neuromuscular Blocking Agent (NMBA) Products Offered 11.1.5 AbbVie Recent Development 11.2 GlaxoSmithKline 11.2.1 GlaxoSmithKline Corporation Information 11.2.2 GlaxoSmithKline Description, Business Overview and Total Revenue 11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 11.2.4 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Products Offered 11.2.5 GlaxoSmithKline Recent Development 11.3 Pfizer 11.3.1 Pfizer Corporation Information 11.3.2 Pfizer Description, Business Overview and Total Revenue 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Pfizer Neuromuscular Blocking Agent (NMBA) Products Offered 11.3.5 Pfizer Recent Development 11.4 Hengrui Pharmaceutical 11.4.1 Hengrui Pharmaceutical Corporation Information 11.4.2 Hengrui Pharmaceutical Description, Business Overview and Total Revenue 11.4.3 Hengrui Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Products Offered 11.4.5 Hengrui Pharmaceutical Recent Development 11.5 Abbott Laboratories 11.5.1 Abbott Laboratories Corporation Information 11.5.2 Abbott Laboratories Description, Business Overview and Total Revenue 11.5.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Products Offered 11.5.5 Abbott Laboratories Recent Development 11.6 Fresenius Kabi 11.6.1 Fresenius Kabi Corporation Information 11.6.2 Fresenius Kabi Description, Business Overview and Total Revenue 11.6.3 Fresenius Kabi Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Products Offered 11.6.5 Fresenius Kabi Recent Development 11.7 Sandoz 11.7.1 Sandoz Corporation Information 11.7.2 Sandoz Description, Business Overview and Total Revenue 11.7.3 Sandoz Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Sandoz Neuromuscular Blocking Agent (NMBA) Products Offered 11.7.5 Sandoz Recent Development 11.8 Somerset Therapeutics 11.8.1 Somerset Therapeutics Corporation Information 11.8.2 Somerset Therapeutics Description, Business Overview and Total Revenue 11.8.3 Somerset Therapeutics Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Products Offered 11.8.5 Somerset Therapeutics Recent Development 11.9 Guike Pharmaceutical 11.9.1 Guike Pharmaceutical Corporation Information 11.9.2 Guike Pharmaceutical Description, Business Overview and Total Revenue 11.9.3 Guike Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Products Offered 11.9.5 Guike Pharmaceutical Recent Development 11.10 Shanghai Pharmaceuticals 11.10.1 Shanghai Pharmaceuticals Corporation Information 11.10.2 Shanghai Pharmaceuticals Description, Business Overview and Total Revenue 11.10.3 Shanghai Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 11.10.4 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Products Offered 11.10.5 Shanghai Pharmaceuticals Recent Development 11.1 AbbVie 11.1.1 AbbVie Corporation Information 11.1.2 AbbVie Description, Business Overview and Total Revenue 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020) 11.1.4 AbbVie Neuromuscular Blocking Agent (NMBA) Products Offered 11.1.5 AbbVie Recent Development 11.12 Nanjing King-Friend 11.12.1 Nanjing King-Friend Corporation Information 11.12.2 Nanjing King-Friend Description, Business Overview and Total Revenue 11.12.3 Nanjing King-Friend Sales, Revenue and Gross Margin (2015-2020) 11.12.4 Nanjing King-Friend Products Offered 11.12.5 Nanjing King-Friend Recent Development 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Neuromuscular Blocking Agent (NMBA) Market Estimates and Projections by Region 12.1.1 Global Neuromuscular Blocking Agent (NMBA) Sales Forecast by Regions 2021-2026 12.1.2 Global Neuromuscular Blocking Agent (NMBA) Revenue Forecast by Regions 2021-2026 12.2 North America Neuromuscular Blocking Agent (NMBA) Market Size Forecast (2021-2026) 12.2.1 North America: Neuromuscular Blocking Agent (NMBA) Sales Forecast (2021-2026) 12.2.2 North America: Neuromuscular Blocking Agent (NMBA) Revenue Forecast (2021-2026) 12.2.3 North America: Neuromuscular Blocking Agent (NMBA) Market Size Forecast by Country (2021-2026) 12.3 Europe Neuromuscular Blocking Agent (NMBA) Market Size Forecast (2021-2026) 12.3.1 Europe: Neuromuscular Blocking Agent (NMBA) Sales Forecast (2021-2026) 12.3.2 Europe: Neuromuscular Blocking Agent (NMBA) Revenue Forecast (2021-2026) 12.3.3 Europe: Neuromuscular Blocking Agent (NMBA) Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Neuromuscular Blocking Agent (NMBA) Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Neuromuscular Blocking Agent (NMBA) Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Neuromuscular Blocking Agent (NMBA) Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Neuromuscular Blocking Agent (NMBA) Market Size Forecast by Region (2021-2026) 12.5 Latin America Neuromuscular Blocking Agent (NMBA) Market Size Forecast (2021-2026) 12.5.1 Latin America: Neuromuscular Blocking Agent (NMBA) Sales Forecast (2021-2026) 12.5.2 Latin America: Neuromuscular Blocking Agent (NMBA) Revenue Forecast (2021-2026) 12.5.3 Latin America: Neuromuscular Blocking Agent (NMBA) Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Neuromuscular Blocking Agent (NMBA) Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Neuromuscular Blocking Agent (NMBA) Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Neuromuscular Blocking Agent (NMBA) Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Neuromuscular Blocking Agent (NMBA) Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter?s Five Forces Analysis 13.5 Primary Interviews with Key Neuromuscular Blocking Agent (NMBA) Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Neuromuscular Blocking Agent (NMBA) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details
